Traditional group (n = 60) | ERAS group (n = 60) | p value (t/Z) | |||||
---|---|---|---|---|---|---|---|
LOS | 5.65 ± 1.39 | 3.47 ± 1.14 | P < 0.0001 (9.393) | ||||
Preoperative VAS scores | 7.25 ± 0.79 | 7.52 ± 1.17 | 0.141 (1.481) | ||||
VAS scores 1 day after operation | 3.33 ± 0.60 | 2.25 ± 0.82 | P < 0.0001 (8.233) | ||||
VAS scores 2 days after operation | 3.07 ± 0.66 | 1.87 ± 0.50 | P < 0.0001 (11.226) | ||||
VAS scores 3 days after operation | 2.25 ± 0.47 | 1.47 ± 0.54 | P < 0.0001 (8.440) | ||||
1 month postoperative VAS scores | 1.13 ± 0.50 | 1.0 ± 0.45 | 0.137 (1.497) | ||||
Preoperative ODI | 62.65 ± 14.62 | 61.45 ± 12.51 | 0.630 (0.483) | ||||
ODI 3 days after operation | 19.55 ± 7.24 | 16.35 ± 6.80 | 0.014 (2.496) | ||||
ODI 1 month after operation | 6.65 ± 2.15 | 6.07 ± 3.16 | 0.242 (1.176) | ||||
Evaluation criteria of improved MacNab efficacy | Excellent | Good | Fair | Excellent | Good | Fair | 0.583 (0.545) |
50 | 5 | 5 | 52 | 5 | 3 | ||
Hospitalization expenses (Ұ) | 32,193.4 ± 4883.46 | 31,234.45 ± 4314.52 | 0.257 (1.140) |